Anders Hjerpe
Papers
1
Total Citations
35
H-Index
1
About
Dr. Anders Hjerpe is a leading figure in mesothelioma research, with a career dedicated to understanding and combating this aggressive thoracic cancer. His work is centered on translational oncology, specifically the ex vivo characterization of malignant mesothelioma to improve patient outcomes. His most cited study, "Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions" (2014, 35 citations), represents a pivotal contribution to the field. In this work, Dr. Hjerpe pioneered a method to culture primary mesothelioma cells directly from patient pleural effusions and subject them to a chemosensitivity assay. This approach directly addressed the critical clinical problem that only 40% of patients respond to standard first-line therapy. By demonstrating the feasibility of profiling individual tumors, his research laid the groundwork for personalized treatment selection, aiming to predict the most effective chemotherapy for each patient. This innovative strategy has had a lasting impact, providing a vital tool for both basic research and clinical decision-making in a disease with a notoriously poor prognosis.
Research Focus
Key Achievements
Top Papers
- 1